PRICE T ROWE ASSOCIATES INC 13D/13G Filings for Iovance Biotherapeutics, Inc. (IOVA)

PRICE T ROWE ASSOCIATES INC 13D and 13G filings for Iovance Biotherapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-14
2:34 pm
Sale		 2021-12-31 13G Iovance Biotherapeutics, Inc.
IOVA		 PRICE T ROWE ASSOCIATES INC 4,663,785
2.900%		 -2,718,420decrease
(-36.82%)		 Filing
2021-02-16
12:23 pm
Purchase		 2020-12-31 13G Iovance Biotherapeutics, Inc.
IOVA		 PRICE T ROWE ASSOCIATES INC 7,382,205
5.000%		 872,349increase
(+13.40%)		 Filing